Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $13.8 Million - $16.1 Million
-144,660 Reduced 54.78%
119,427 $13.1 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $23.9 Million - $27.6 Million
246,515 Added 1402.89%
264,087 $25.6 Million
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $106,356 - $128,551
1,042 Added 6.3%
17,572 $1.91 Million
Q1 2019

May 10, 2019

BUY
$66.22 - $80.06 $901,717 - $1.09 Million
13,617 Added 467.46%
16,530 $1.32 Million
Q2 2018

Aug 08, 2018

SELL
$57.57 - $63.54 $1.03 Million - $1.13 Million
-17,817 Reduced 85.95%
2,913 $178,000
Q1 2018

May 09, 2018

BUY
$56.27 - $63.62 $1.17 Million - $1.32 Million
20,730 New
20,730 $1.24 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.